Lorrain Daniel S.'s Form 4 filing
Contineum Therapeutics, Inc. (CTNM) · filed Dec 30, 2025
- Accession no.
- 0001437749-25-038936
- Filed
- Dec 30, 2025
- Trade date
- Dec 23, 2025
- Filing delay
- 7 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $51.0K. It was filed 7 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lorrain Daniel S.CIK 0001861550 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | Class A Common Stock | SSaleDisposed | −4,170 | $12.23 | −$50,999.1 | 164,392 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.